154 related articles for article (PubMed ID: 16305584)
1. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
[TBL] [Abstract][Full Text] [Related]
2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
3. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.
Ammari WG; Oriquat GA; Sanders M
Eur J Pharm Sci; 2020 Apr; 147():105304. PubMed ID: 32165316
[TBL] [Abstract][Full Text] [Related]
6. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser.
Silkstone VL; Corlett SA; Chrystyn H
Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799
[TBL] [Abstract][Full Text] [Related]
7. Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler DPI.
Newhouse MT; Patel P; Parry-Billings M
Eur Respir J; 2003 May; 21(5):816-20. PubMed ID: 12765427
[TBL] [Abstract][Full Text] [Related]
8. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationship and reproducibility of urinary salbutamol excretion during the first 30 min after an inhalation.
Tomlinson HS; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2003 Aug; 56(2):225-7. PubMed ID: 12895197
[TBL] [Abstract][Full Text] [Related]
10. Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.
Silkstone VL; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2002 Aug; 54(2):115-9. PubMed ID: 12207629
[TBL] [Abstract][Full Text] [Related]
11. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
12. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers.
Creticos PS; Adams WP; Petty BG; Lewis LD; Singh GJ; Khattignavong AP; Molzon JA; Martinez MN; Lietman PS; Williams RL
J Allergy Clin Immunol; 2002 Nov; 110(5):713-20. PubMed ID: 12417879
[TBL] [Abstract][Full Text] [Related]
13. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.
Mallol J; Aguirre V; Rhem R; Rodriguez J; Dolovich M
Pediatr Pulmonol; 2001 Dec; 32(6):447-52. PubMed ID: 11747248
[TBL] [Abstract][Full Text] [Related]
15. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
16. The relative bioavailability of salbutamol to the lung using urinary excretion following inhalation from a novel dry powder inhaler: the effect of inhalation rate and formulation.
Chege JK; Chrystyn H
Respir Med; 2000 Jan; 94(1):51-6. PubMed ID: 10714479
[TBL] [Abstract][Full Text] [Related]
17. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
18. A Randomized Controlled Trial of 2 Inhalation Methods When Using a Pressurized Metered Dose Inhaler With Valved Holding Chamber.
Stephen D; Vatsa M; Lodha R; Kabra SK
Respir Care; 2015 Dec; 60(12):1743-8. PubMed ID: 26081179
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.
Silkstone VL; Tomlinson HS; Corlett SA; Chrystyn H
Br J Clin Pharmacol; 2000 Sep; 50(3):281-4. PubMed ID: 10971315
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.
Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K
Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
